Beta-Lactam InfusioN Group Study
- Conditions
- Sepsis
- Interventions
- Other: Intermittent infusionOther: Continuous infusion
- First Posted Date
- 2017-07-11
- Last Posted Date
- 2023-12-12
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 7203
- Registration Number
- NCT03213990
- Locations
- 🇦🇺
Blacktown Hospital, Blacktown, New South Wales, Australia
🇸🇪Skane Lund University Hospital, Lund, Sweden
🇦🇺The Wesley Hospital, Auchenflower, Queensland, Australia
Plasma-Lyte 148® versUs Saline Study
- First Posted Date
- 2016-03-29
- Last Posted Date
- 2023-08-08
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 5037
- Registration Number
- NCT02721654
- Locations
- 🇦🇺
Fiona Stanley Hospital, Murdoch, Western Australia, Australia
🇦🇺Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
🇦🇺Blacktown Hospital, Blacktown, New South Wales, Australia
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial
- Conditions
- Intracerebral Haemorrhage (ICH)Hypertension
- Interventions
- First Posted Date
- 2016-03-04
- Last Posted Date
- 2024-04-22
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 1600
- Registration Number
- NCT02699645
- Locations
- 🇳🇱
Zuyderland Medical Centre, Heerlen, Netherlands
🇳🇱Radboud University Medical Center, Nijmegen, Netherlands
🇦🇺Fiona Stanley Hospital, Murdoch, Western Australia, Australia
Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients
- Conditions
- Septic ShockVentilator Associated PneumoniaSepsisCritical Illness
- Interventions
- Drug: SDD Oral PasteDrug: SDD Gastric SuspensionDrug: Intravenous Antibiotic
- First Posted Date
- 2015-03-17
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 20010
- Registration Number
- NCT02389036
- Locations
- 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Canada
🇦🇺The George Institute for Global Health, Sydney, New South Wales, Australia
🇬🇧Imperial College London, London, United Kingdom
A Trial to Determine the Effects of a Behavioural Communication Strategy on Salt Levels in Foods
- Conditions
- Reducing Salt in the Food Supply
- Interventions
- Other: Advocacy
- First Posted Date
- 2015-02-27
- Last Posted Date
- 2017-05-04
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 45
- Registration Number
- NCT02373423
Theophylline and Steroids in Chronic Obstructive Pulmonary Disease (COPD) Study
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- First Posted Date
- 2014-10-10
- Last Posted Date
- 2021-08-12
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 1670
- Registration Number
- NCT02261727
- Locations
- 🇦🇺
The George Institute for Global Health, Sydney, New South Wales, Australia
Head Position in Stroke Trial (HeadPoST)
- Conditions
- Intracerebral HaemorrhageIschemic Stroke
- Interventions
- Other: The lying flat (0°) head position for 24 hoursOther: The sitting-up (≥30°) head position for 24 hours
- First Posted Date
- 2014-06-12
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 11096
- Registration Number
- NCT02162017
- Locations
- 🇦🇺
The George Institute for Global Health, Sydney, New South Wales, Australia
Changing Population Salt Consumption in Lithgow, Australia
- Conditions
- HypertensionCardiovascular DiseaseBlood Pressure
- Interventions
- Behavioral: Community-based salt reduction
- First Posted Date
- 2014-04-07
- Last Posted Date
- 2014-11-18
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 991
- Registration Number
- NCT02105727
- Locations
- 🇦🇺
The George Institute for Global Health, Camperdown, New South Wales, Australia
China Salt Substitute and Stroke Study
- Conditions
- Stroke
- Interventions
- Behavioral: Dietary sodium reduction
- First Posted Date
- 2014-03-19
- Last Posted Date
- 2021-04-08
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 20996
- Registration Number
- NCT02092090
- Locations
- 🇨🇳
China Medical Universtity, Shenyang, Liaoning, China
🇨🇳Hebei Province Centre for Disease Control and Prevention, Shijiazhuang, Hebei, China
🇨🇳Changzhi Medical Colledge, Changzhi, Shanxi, China
Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)
- Conditions
- IgA Glomerulonephritis
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-03-21
- Last Posted Date
- 2021-09-23
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 503
- Registration Number
- NCT01560052
- Locations
- 🇦🇺
Concord Repatriation and General Hospital, Concord, New South Wales, Australia
🇦🇺Nepean Hospital, Kingswood, New South Wales, Australia
🇦🇺Royal North Shore Hospital, St Leonards, New South Wales, Australia